Replicate Bioscience creates novel oncology treatments to prevent and reverse drug resistance through a self-replicating RNA platform. Founded by Andrew Geall, Herbert Kim Lyerly, Nathaniel Wang, and Zachary Hartman in 2021Replicate Bioscience is backed by Apple Tree Partners and is headquartered in San Diego.